Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Am Coll Cardiol ; 34(2): 402-8, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10440152

RESUMO

OBJECTIVES: The present study was designed to assess the extent of myocardial injury in patients undergoing transvenous implantation of an automatic implantable cardioverter-defibrillator (ICD) using cardiac troponin I (cTNI), which is a highly specific marker of structural cardiac injury. BACKGROUND: During ICD implantation, repetitive induction and termination of ventricular fibrillation (VF) via endocardial direct current shocks is required to demonstrate the correct function of the device. Transthoracic electrical shocks can cause myocardial cell injury. METHODS: Measurements of total creatine kinase (CK), CK-MB, myoglobin, cardiac troponin T (cTNT) and cTNI were obtained before and after ICD implantation in 49 consecutive patients. Blood samples were drawn before and 2, 4, 8, and 24 h after implantation. RESULTS: Elevations of CK, CK-MB, myoglobin, cTNT and cTNI above cut-off level were found in 25%, 6%, 76%, 37% and 14% of patients, respectively, with peak cTNI concentrations ranging from 1.7 to 5.5 ng/ml. Cumulative defibrillation energy (DFE), mean DFE, cumulative VF time, number of shocks as well as prior myocardial infarction (MI) were found to be significantly related to a rise of cTNI. Mean DFE > or = 18 J and a recent MI were identified as strong risk factors for cTNI rise. CONCLUSIONS: During transvenous ICD implantation myocardial injury as assessed by cTNI rise occurs in about 14% of the patients. Peak cTNI concentrations are only minimally elevated reflecting subtle myocardial cell damage. Patients with a recent MI and a mean DFE > or = 18 J seem to be prone to cTNI rise.


Assuntos
Estimulação Cardíaca Artificial/efeitos adversos , Desfibriladores Implantáveis/efeitos adversos , Traumatismos Cardíacos/etiologia , Biomarcadores/sangue , Creatina Quinase/sangue , Feminino , Traumatismos Cardíacos/diagnóstico , Humanos , Isoenzimas , Masculino , Pessoa de Meia-Idade , Mioglobina/sangue , Troponina I/sangue , Troponina T/sangue
2.
Am J Cardiol ; 88(7): 744-9, 2001 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-11589840

RESUMO

Inappropriate shock therapy is a frequent problem in patients with implantable cardioverter-defibrillators (ICDs), caused mostly by supraventricular rhythms. Self-terminating ventricular arrhythmias (STVAs), however, may also lead to inappropriate shock discharges even in ICDs with abortive shock capabilities. The aim of this study was to evaluate the clinical performance of a specific ventricular tachycardia/ventricular fibrillation (VT/VF) reconfirmation algorithm implemented in current ICD devices from Medtronic to prevent inappropriate shock discharges due to STVAs. A total of 161 STVA episodes were documented in 59 of 150 patients (39%) within a mean follow-up of 30 +/- 20 months and resulted in 25 inappropriate shock discharges in 15 of 150 patients (10%) despite activation of the reconfirmation algorithm. The first synchronization interval of the algorithm was met in 92% of STVA episodes with and even 38% of STVA episodes without shock delivery. A reduced incidence of inappropriate shocks due to STVAs was found with tachycardia/fibrillation detection intervals (TDI/FDI) programmed to shorter cycle lengths < or =280 ms or the use of the first 2 cycles after the end of charging to be considered for reconfirmation only. Thus, inappropriate shocks due to STVAs still occur in 10% of patients with ICDs despite activation of a specific VT/VF reconfirmation algorithm, and are mainly caused by meeting the first synchronization interval that therefore should be shortened in cycle length. Moreover, to reduce the likelihood of inappropriate shocks, the VF reconfirmation algorithm should be optimized by basing the synchronization intervals exclusively on the FDI with short cycle lengths or using the first 2 cycles for reconfirmation only.


Assuntos
Algoritmos , Desfibriladores Implantáveis , Taquicardia Ventricular/terapia , Distribuição de Qui-Quadrado , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estatísticas não Paramétricas
3.
Pacing Clin Electrophysiol ; 20(5 Pt 1): 1328-31, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9170134

RESUMO

Algorithms that attempt to reconfirm the presence of an arrhythmia prior to definite treatment have been implemented in ICDs to prevent inappropriate shock therapy due to self-terminating ventricular arrhythmias. Nevertheless, in two patients, clinically inappropriate shocks were delivered after spontaneous conversion of the arrhythmia despite the use of a specific reconfirmation algorithm. Reconfirmation criteria were met due to a premature ventricular complex causing a short cycle in the first patient and a long postextrasystolic pause in the second patient. To avoid inappropriate shock therapy due to self-terminating ventricular arrhythmias, further improvement of detection algorithms is required.


Assuntos
Desfibriladores Implantáveis , Taquicardia Ventricular/terapia , Algoritmos , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA